Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tbp
|
ENSMUSG00000014767.10 | TATA box binding protein |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_15501021_15501190 | Tbp | 1145 | 0.289167 | -0.30 | 2.0e-02 | Click! |
chr17_15501788_15502060 | Tbp | 1065 | 0.344366 | -0.12 | 3.8e-01 | Click! |
chr17_15499944_15500637 | Tbp | 330 | 0.608449 | -0.08 | 5.2e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_86169744_86170730 | 6.59 |
Prkce |
protein kinase C, epsilon |
2063 |
0.32 |
chr16_43504464_43505047 | 4.72 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
1058 |
0.61 |
chr5_57723598_57724600 | 4.38 |
Gm42635 |
predicted gene 42635 |
294 |
0.83 |
chr10_77339253_77340474 | 4.34 |
Adarb1 |
adenosine deaminase, RNA-specific, B1 |
313 |
0.91 |
chr12_15812207_15812700 | 4.13 |
Trib2 |
tribbles pseudokinase 2 |
4332 |
0.17 |
chr8_72320830_72321486 | 4.02 |
Klf2 |
Kruppel-like factor 2 (lung) |
2125 |
0.21 |
chr16_65560252_65560595 | 3.85 |
Chmp2b |
charged multivesicular body protein 2B |
2097 |
0.32 |
chr6_136170568_136170996 | 3.83 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
1107 |
0.5 |
chr19_58979595_58980175 | 3.74 |
Eno4 |
enolase 4 |
24429 |
0.16 |
chr1_32174771_32175297 | 3.57 |
Khdrbs2 |
KH domain containing, RNA binding, signal transduction associated 2 |
2147 |
0.41 |
chr10_33083961_33084356 | 3.46 |
Trdn |
triadin |
597 |
0.81 |
chr15_12738219_12738508 | 3.40 |
Pdzd2 |
PDZ domain containing 2 |
1561 |
0.32 |
chrX_95195580_95195768 | 3.15 |
Arhgef9 |
CDC42 guanine nucleotide exchange factor (GEF) 9 |
778 |
0.67 |
chr10_38968014_38968667 | 3.14 |
Lama4 |
laminin, alpha 4 |
2668 |
0.33 |
chr4_13744961_13745583 | 3.14 |
Runx1t1 |
RUNX1 translocation partner 1 |
1836 |
0.49 |
chr9_101197719_101198068 | 3.13 |
Ppp2r3a |
protein phosphatase 2, regulatory subunit B'', alpha |
958 |
0.44 |
chr19_37176789_37177437 | 3.02 |
Cpeb3 |
cytoplasmic polyadenylation element binding protein 3 |
904 |
0.43 |
chr4_116223265_116224130 | 2.93 |
Pik3r3 |
phosphoinositide-3-kinase regulatory subunit 3 |
2001 |
0.23 |
chr14_76419153_76419898 | 2.89 |
Tsc22d1 |
TSC22 domain family, member 1 |
697 |
0.78 |
chr13_77045531_77045791 | 2.89 |
Slf1 |
SMC5-SMC6 complex localization factor 1 |
1736 |
0.48 |
chr11_54596874_54597434 | 2.88 |
Rapgef6 |
Rap guanine nucleotide exchange factor (GEF) 6 |
980 |
0.6 |
chr10_90830503_90831025 | 2.86 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
921 |
0.56 |
chr1_59766087_59766553 | 2.83 |
Bmpr2 |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
2920 |
0.2 |
chr2_65622009_65622167 | 2.81 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
1277 |
0.54 |
chr5_98028905_98029056 | 2.79 |
Antxr2 |
anthrax toxin receptor 2 |
1982 |
0.25 |
chr14_93883348_93883774 | 2.77 |
Pcdh9 |
protocadherin 9 |
2187 |
0.43 |
chr12_31711352_31711698 | 2.76 |
Gpr22 |
G protein-coupled receptor 22 |
2401 |
0.25 |
chr12_76082482_76082659 | 2.76 |
Syne2 |
spectrin repeat containing, nuclear envelope 2 |
631 |
0.77 |
chr9_94535439_94536002 | 2.74 |
Dipk2a |
divergent protein kinase domain 2A |
2361 |
0.35 |
chr13_113662906_113663717 | 2.73 |
Hspb3 |
heat shock protein 3 |
365 |
0.85 |
chr12_31713469_31714088 | 2.71 |
Gpr22 |
G protein-coupled receptor 22 |
148 |
0.95 |
chr18_43389837_43390467 | 2.66 |
Dpysl3 |
dihydropyrimidinase-like 3 |
3225 |
0.29 |
chr2_17458500_17459039 | 2.61 |
Nebl |
nebulette |
1852 |
0.47 |
chr11_87073017_87073174 | 2.58 |
Gdpd1 |
glycerophosphodiester phosphodiesterase domain containing 1 |
967 |
0.35 |
chr7_73555476_73555660 | 2.58 |
1810026B05Rik |
RIKEN cDNA 1810026B05 gene |
352 |
0.79 |
chr1_98093832_98094116 | 2.56 |
Pam |
peptidylglycine alpha-amidating monooxygenase |
1647 |
0.36 |
chr17_81667571_81668254 | 2.55 |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
2275 |
0.44 |
chr5_84414084_84414723 | 2.51 |
Epha5 |
Eph receptor A5 |
2403 |
0.37 |
chr5_57723103_57723321 | 2.47 |
Pcdh7 |
protocadherin 7 |
1003 |
0.34 |
chr16_28752323_28752539 | 2.47 |
Fgf12 |
fibroblast growth factor 12 |
637 |
0.82 |
chr10_73821409_73822534 | 2.45 |
Pcdh15 |
protocadherin 15 |
28 |
0.99 |
chr8_14382368_14383445 | 2.45 |
Dlgap2 |
DLG associated protein 2 |
910 |
0.66 |
chr1_119419067_119420042 | 2.44 |
Inhbb |
inhibin beta-B |
2694 |
0.27 |
chr2_82056608_82056868 | 2.42 |
Zfp804a |
zinc finger protein 804A |
3516 |
0.36 |
chr12_95699008_95699374 | 2.39 |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
3834 |
0.21 |
chr14_117895283_117895843 | 2.39 |
Mir6239 |
microRNA 6239 |
58284 |
0.14 |
chr4_43383267_43383629 | 2.36 |
Rusc2 |
RUN and SH3 domain containing 2 |
1 |
0.97 |
chr8_126258287_126258531 | 2.36 |
Slc35f3 |
solute carrier family 35, member F3 |
40149 |
0.19 |
chr17_10307978_10308514 | 2.36 |
Qk |
quaking |
11115 |
0.23 |
chr4_82496866_82497618 | 2.34 |
Nfib |
nuclear factor I/B |
2074 |
0.34 |
chr9_112232861_112233588 | 2.33 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
402 |
0.75 |
chr16_4522019_4522667 | 2.33 |
Srl |
sarcalumenin |
720 |
0.62 |
chr8_45658542_45659771 | 2.33 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
352 |
0.89 |
chr14_96517868_96518996 | 2.32 |
Klhl1 |
kelch-like 1 |
670 |
0.78 |
chr5_43239013_43240191 | 2.32 |
Cpeb2 |
cytoplasmic polyadenylation element binding protein 2 |
2287 |
0.23 |
chr3_80080026_80080661 | 2.32 |
Gm19066 |
predicted gene, 19066 |
8816 |
0.2 |
chr2_131845877_131846076 | 2.31 |
Gm14282 |
predicted gene 14282 |
381 |
0.47 |
chr5_150261018_150262108 | 2.29 |
Fry |
FRY microtubule binding protein |
1796 |
0.34 |
chr14_64834470_64835221 | 2.28 |
Gm20111 |
predicted gene, 20111 |
4255 |
0.18 |
chr18_69349496_69350227 | 2.28 |
Tcf4 |
transcription factor 4 |
917 |
0.69 |
chr6_67228511_67229348 | 2.28 |
Gm44052 |
predicted gene, 44052 |
6385 |
0.13 |
chr1_25832036_25832712 | 2.28 |
Gm9884 |
predicted gene 9884 |
1717 |
0.22 |
chr10_69536775_69537233 | 2.26 |
Ank3 |
ankyrin 3, epithelial |
2782 |
0.32 |
chr18_25752531_25753655 | 2.24 |
Celf4 |
CUGBP, Elav-like family member 4 |
401 |
0.88 |
chr6_18511684_18512389 | 2.23 |
Cttnbp2 |
cortactin binding protein 2 |
1055 |
0.59 |
chr11_112620876_112621428 | 2.22 |
BC006965 |
cDNA sequence BC006965 |
48246 |
0.19 |
chr4_42951254_42951979 | 2.22 |
Dnajb5 |
DnaJ heat shock protein family (Hsp40) member B5 |
1176 |
0.34 |
chr2_155611238_155612364 | 2.22 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
589 |
0.53 |
chr12_61525470_61525621 | 2.21 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
1597 |
0.38 |
chr16_38092491_38092682 | 2.21 |
Gsk3b |
glycogen synthase kinase 3 beta |
2298 |
0.34 |
chrX_88114828_88115362 | 2.19 |
Il1rapl1 |
interleukin 1 receptor accessory protein-like 1 |
550 |
0.84 |
chr4_147985863_147986206 | 2.19 |
Nppb |
natriuretic peptide type B |
246 |
0.85 |
chr17_10311671_10311978 | 2.16 |
Qk |
quaking |
7537 |
0.24 |
chrX_9201266_9201702 | 2.15 |
Lancl3 |
LanC lantibiotic synthetase component C-like 3 (bacterial) |
1582 |
0.33 |
chr15_96282547_96282837 | 2.15 |
2610037D02Rik |
RIKEN cDNA 2610037D02 gene |
916 |
0.58 |
chr8_50321671_50321892 | 2.14 |
Gm2516 |
predicted gene 2516 |
46331 |
0.17 |
chr19_28165559_28166176 | 2.13 |
Gm35781 |
predicted gene, 35781 |
19564 |
0.23 |
chr4_116405618_116406369 | 2.12 |
Mast2 |
microtubule associated serine/threonine kinase 2 |
7 |
0.98 |
chr5_103208286_103208708 | 2.11 |
Mapk10 |
mitogen-activated protein kinase 10 |
515 |
0.84 |
chr8_34889322_34889790 | 2.09 |
Tnks |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase |
595 |
0.79 |
chr3_149442630_149443040 | 2.08 |
Gm30382 |
predicted gene, 30382 |
2441 |
0.4 |
chr13_24640514_24640935 | 2.07 |
Ripor2 |
RHO family interacting cell polarization regulator 2 |
2011 |
0.34 |
chr7_92237123_92237313 | 2.05 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
2091 |
0.42 |
chr5_144257814_144258808 | 2.04 |
2900089D17Rik |
RIKEN cDNA 2900089D17 gene |
2125 |
0.2 |
chr10_121836526_121837955 | 2.04 |
Gm48804 |
predicted gene, 48804 |
5182 |
0.22 |
chr6_136875262_136875841 | 2.03 |
Mgp |
matrix Gla protein |
230 |
0.87 |
chrX_157701658_157702782 | 2.03 |
Smpx |
small muscle protein, X-linked |
378 |
0.83 |
chr14_6286765_6287923 | 2.03 |
Gm3411 |
predicted gene 3411 |
94 |
0.95 |
chr8_109250241_109250821 | 2.00 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
665 |
0.8 |
chr2_52557337_52558561 | 1.99 |
Cacnb4 |
calcium channel, voltage-dependent, beta 4 subunit |
611 |
0.74 |
chr5_107498136_107498752 | 1.99 |
Btbd8 |
BTB (POZ) domain containing 8 |
665 |
0.57 |
chr2_116055093_116055619 | 1.98 |
Meis2 |
Meis homeobox 2 |
3486 |
0.22 |
chr9_100505452_100505603 | 1.97 |
Nck1 |
non-catalytic region of tyrosine kinase adaptor protein 1 |
1329 |
0.37 |
chr12_29528407_29529244 | 1.96 |
Myt1l |
myelin transcription factor 1-like |
424 |
0.85 |
chr9_50752994_50754649 | 1.96 |
Cryab |
crystallin, alpha B |
574 |
0.54 |
chr19_36736024_36736690 | 1.95 |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
296 |
0.92 |
chr12_41485290_41486156 | 1.95 |
Lrrn3 |
leucine rich repeat protein 3, neuronal |
708 |
0.74 |
chr19_15516574_15517276 | 1.93 |
Gm24319 |
predicted gene, 24319 |
163079 |
0.04 |
chr8_13253441_13254226 | 1.93 |
Adprhl1 |
ADP-ribosylhydrolase like 1 |
238 |
0.86 |
chr13_105052879_105053209 | 1.92 |
Rgs7bp |
regulator of G-protein signalling 7 binding protein |
1886 |
0.41 |
chr3_52510208_52510569 | 1.90 |
Gm30173 |
predicted gene, 30173 |
6576 |
0.26 |
chr15_100914634_100914945 | 1.90 |
Scn8a |
sodium channel, voltage-gated, type VIII, alpha |
18640 |
0.18 |
chr12_71312067_71312327 | 1.90 |
Dact1 |
dishevelled-binding antagonist of beta-catenin 1 |
2213 |
0.24 |
chr4_48042086_48042237 | 1.89 |
Nr4a3 |
nuclear receptor subfamily 4, group A, member 3 |
2992 |
0.3 |
chr4_46989792_46990047 | 1.89 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
1954 |
0.3 |
chr7_140899782_140900558 | 1.88 |
Cox8b |
cytochrome c oxidase subunit 8B |
276 |
0.74 |
chr15_40656769_40657228 | 1.88 |
Zfpm2 |
zinc finger protein, multitype 2 |
1647 |
0.51 |
chr2_14823792_14824714 | 1.87 |
Cacnb2 |
calcium channel, voltage-dependent, beta 2 subunit |
161 |
0.94 |
chr2_55439535_55439810 | 1.87 |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
2507 |
0.37 |
chr4_141421681_141422558 | 1.86 |
Hspb7 |
heat shock protein family, member 7 (cardiovascular) |
1340 |
0.25 |
chr13_83728524_83729044 | 1.85 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
678 |
0.43 |
chr3_114065499_114066238 | 1.85 |
Col11a1 |
collagen, type XI, alpha 1 |
5426 |
0.34 |
chr5_104113204_104114091 | 1.84 |
Sparcl1 |
SPARC-like 1 |
86 |
0.71 |
chr6_93911862_93913573 | 1.83 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
213 |
0.95 |
chr2_34365639_34365833 | 1.83 |
Pbx3 |
pre B cell leukemia homeobox 3 |
5110 |
0.22 |
chr4_91373554_91373705 | 1.83 |
Mir6402 |
microRNA 6402 |
266 |
0.75 |
chr3_114906056_114906421 | 1.82 |
Olfm3 |
olfactomedin 3 |
1603 |
0.51 |
chr3_134302539_134303851 | 1.82 |
Gm43559 |
predicted gene 43559 |
30685 |
0.13 |
chr16_43510843_43511293 | 1.82 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
760 |
0.73 |
chr7_65154721_65155254 | 1.82 |
Fam189a1 |
family with sequence similarity 189, member A1 |
1429 |
0.4 |
chr3_19646067_19646346 | 1.82 |
Trim55 |
tripartite motif-containing 55 |
1698 |
0.31 |
chr17_78454131_78454627 | 1.81 |
Gm19399 |
predicted gene, 19399 |
4266 |
0.19 |
chr1_135836765_135837624 | 1.81 |
Tnnt2 |
troponin T2, cardiac |
781 |
0.54 |
chr5_74676974_74677904 | 1.81 |
Lnx1 |
ligand of numb-protein X 1 |
190 |
0.94 |
chr2_19344284_19344843 | 1.80 |
4930447M23Rik |
RIKEN cDNA 4930447M23 gene |
246 |
0.93 |
chr8_72321900_72322170 | 1.80 |
Klf2 |
Kruppel-like factor 2 (lung) |
3002 |
0.17 |
chr1_25826538_25826915 | 1.79 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
34 |
0.95 |
chr14_66344363_66345813 | 1.78 |
Stmn4 |
stathmin-like 4 |
707 |
0.65 |
chr7_99270025_99270176 | 1.78 |
Map6 |
microtubule-associated protein 6 |
968 |
0.42 |
chr2_78959558_78959850 | 1.78 |
Gm37004 |
predicted gene, 37004 |
12968 |
0.21 |
chr8_118285307_118286252 | 1.78 |
Cdh13 |
cadherin 13 |
1982 |
0.46 |
chr6_12260319_12260631 | 1.77 |
Thsd7a |
thrombospondin, type I, domain containing 7A |
57854 |
0.15 |
chr11_116652562_116653193 | 1.77 |
Prcd |
photoreceptor disc component |
657 |
0.45 |
chr4_136284704_136285451 | 1.77 |
Zfp46 |
zinc finger protein 46 |
8 |
0.97 |
chr15_51105566_51105788 | 1.76 |
Gm48913 |
predicted gene, 48913 |
208038 |
0.02 |
chr3_123688820_123689480 | 1.75 |
Ndst3 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 |
1130 |
0.37 |
chr10_122046537_122047121 | 1.75 |
Srgap1 |
SLIT-ROBO Rho GTPase activating protein 1 |
479 |
0.76 |
chr2_6869935_6870654 | 1.75 |
Celf2 |
CUGBP, Elav-like family member 2 |
1678 |
0.39 |
chr6_5110035_5110504 | 1.74 |
Ppp1r9a |
protein phosphatase 1, regulatory subunit 9A |
390 |
0.89 |
chr1_3669608_3669968 | 1.73 |
Xkr4 |
X-linked Kx blood group related 4 |
1710 |
0.33 |
chr15_100872381_100872532 | 1.73 |
Scn8a |
sodium channel, voltage-gated, type VIII, alpha |
1036 |
0.52 |
chr5_5264770_5266186 | 1.73 |
Cdk14 |
cyclin-dependent kinase 14 |
169 |
0.96 |
chr4_123405003_123405398 | 1.73 |
Macf1 |
microtubule-actin crosslinking factor 1 |
7028 |
0.17 |
chr17_42319944_42320183 | 1.72 |
Ptchd4 |
patched domain containing 4 |
3463 |
0.39 |
chr5_43776403_43776554 | 1.72 |
Fbxl5 |
F-box and leucine-rich repeat protein 5 |
2878 |
0.16 |
chr9_83663941_83664341 | 1.72 |
Gm36120 |
predicted gene, 36120 |
23384 |
0.17 |
chr4_68951885_68952234 | 1.71 |
Brinp1 |
bone morphogenic protein/retinoic acid inducible neural specific 1 |
2338 |
0.46 |
chr1_143643975_143644626 | 1.71 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
1775 |
0.33 |
chr2_48815764_48816586 | 1.71 |
Acvr2a |
activin receptor IIA |
2066 |
0.36 |
chr2_113828248_113829427 | 1.70 |
Scg5 |
secretogranin V |
75 |
0.97 |
chr10_96622833_96623426 | 1.70 |
Btg1 |
BTG anti-proliferation factor 1 |
5575 |
0.22 |
chr13_110277692_110277997 | 1.70 |
Rab3c |
RAB3C, member RAS oncogene family |
2306 |
0.36 |
chr11_57011668_57012922 | 1.70 |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
339 |
0.94 |
chrX_158027538_158027689 | 1.70 |
Cnksr2 |
connector enhancer of kinase suppressor of Ras 2 |
15681 |
0.26 |
chr2_116068937_116070512 | 1.69 |
G630016G05Rik |
RIKEN cDNA G630016G05 gene |
1756 |
0.28 |
chr2_61453755_61454593 | 1.69 |
Gm22338 |
predicted gene, 22338 |
38592 |
0.2 |
chr10_40969317_40970070 | 1.69 |
Gm48057 |
predicted gene, 48057 |
65502 |
0.09 |
chr5_117240468_117241490 | 1.69 |
Taok3 |
TAO kinase 3 |
519 |
0.72 |
chr6_148046801_148048056 | 1.69 |
Far2 |
fatty acyl CoA reductase 2 |
12 |
0.57 |
chr5_44798941_44799728 | 1.68 |
Ldb2 |
LIM domain binding 2 |
268 |
0.91 |
chr16_32660648_32662499 | 1.68 |
Tnk2 |
tyrosine kinase, non-receptor, 2 |
321 |
0.85 |
chr3_141863014_141863269 | 1.68 |
Bmpr1b |
bone morphogenetic protein receptor, type 1B |
68367 |
0.12 |
chr9_107401822_107402928 | 1.68 |
Cacna2d2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
2306 |
0.19 |
chr13_48263734_48264208 | 1.68 |
A330033J07Rik |
RIKEN cDNA A330033J07 gene |
1348 |
0.26 |
chr7_61311164_61311772 | 1.67 |
A230006K03Rik |
RIKEN cDNA A230006K03 gene |
245 |
0.96 |
chrX_58018762_58019230 | 1.67 |
Zic3 |
zinc finger protein of the cerebellum 3 |
3704 |
0.3 |
chr9_113811975_113812935 | 1.67 |
Clasp2 |
CLIP associating protein 2 |
131 |
0.97 |
chr2_162658795_162659164 | 1.66 |
Ptprt |
protein tyrosine phosphatase, receptor type, T |
2115 |
0.26 |
chr13_83735558_83735982 | 1.66 |
Gm33366 |
predicted gene, 33366 |
2765 |
0.16 |
chr4_97781842_97782066 | 1.66 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
3876 |
0.23 |
chr18_23036665_23037864 | 1.66 |
Nol4 |
nucleolar protein 4 |
1392 |
0.59 |
chr19_5796466_5796984 | 1.66 |
Malat1 |
metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA) |
227 |
0.83 |
chr2_84647361_84647698 | 1.65 |
Ctnnd1 |
catenin (cadherin associated protein), delta 1 |
1008 |
0.34 |
chr1_154689208_154689459 | 1.65 |
Cacna1e |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
36587 |
0.22 |
chr6_96113911_96115198 | 1.65 |
Tafa1 |
TAFA chemokine like family member 1 |
95 |
0.98 |
chr16_38363598_38364152 | 1.65 |
Popdc2 |
popeye domain containing 2 |
1630 |
0.26 |
chr13_44946033_44946635 | 1.65 |
Dtnbp1 |
dystrobrevin binding protein 1 |
810 |
0.7 |
chr10_63457257_63458786 | 1.65 |
Ctnna3 |
catenin (cadherin associated protein), alpha 3 |
511 |
0.78 |
chr7_62208910_62209522 | 1.65 |
Gm9801 |
predicted gene 9801 |
263 |
0.94 |
chr5_17835023_17835212 | 1.64 |
Cd36 |
CD36 molecule |
579 |
0.85 |
chr3_96596227_96596874 | 1.63 |
Ankrd34a |
ankyrin repeat domain 34A |
86 |
0.91 |
chr18_69516358_69516597 | 1.63 |
Tcf4 |
transcription factor 4 |
3002 |
0.34 |
chr2_73659712_73660499 | 1.63 |
Chn1 |
chimerin 1 |
271 |
0.89 |
chr3_108592530_108592701 | 1.63 |
Wdr47 |
WD repeat domain 47 |
1226 |
0.27 |
chr6_92478725_92480195 | 1.63 |
Prickle2 |
prickle planar cell polarity protein 2 |
1932 |
0.44 |
chr1_172616477_172616957 | 1.63 |
Fcrl6 |
Fc receptor-like 6 |
14166 |
0.12 |
chr14_108912235_108913525 | 1.63 |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
1278 |
0.64 |
chrX_10486738_10487122 | 1.63 |
Tspan7 |
tetraspanin 7 |
1772 |
0.4 |
chr10_18410119_18410270 | 1.63 |
Nhsl1 |
NHS-like 1 |
2519 |
0.35 |
chr16_69469508_69470143 | 1.62 |
4930428D20Rik |
RIKEN cDNA 4930428D20 gene |
330556 |
0.01 |
chr16_72402442_72402753 | 1.62 |
Gm49670 |
predicted gene, 49670 |
30156 |
0.24 |
chr10_12613847_12614341 | 1.62 |
Utrn |
utrophin |
737 |
0.78 |
chr15_85680534_85681451 | 1.61 |
Lncppara |
long noncoding RNA near Ppara |
22781 |
0.12 |
chr4_116405137_116405599 | 1.61 |
Mast2 |
microtubule associated serine/threonine kinase 2 |
618 |
0.74 |
chr14_60382061_60382434 | 1.61 |
Amer2 |
APC membrane recruitment 2 |
3961 |
0.26 |
chr2_34357509_34357943 | 1.61 |
Pbx3 |
pre B cell leukemia homeobox 3 |
13120 |
0.19 |
chr2_65846012_65846807 | 1.61 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
554 |
0.79 |
chrX_88112223_88112880 | 1.61 |
Il1rapl1 |
interleukin 1 receptor accessory protein-like 1 |
3094 |
0.35 |
chr11_29375270_29375545 | 1.61 |
Ccdc88a |
coiled coil domain containing 88A |
1059 |
0.45 |
chr4_25798002_25798171 | 1.60 |
Fut9 |
fucosyltransferase 9 |
1769 |
0.36 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 6.8 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
2.0 | 2.0 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.4 | 4.1 | GO:0007525 | somatic muscle development(GO:0007525) |
1.1 | 4.5 | GO:0060486 | Clara cell differentiation(GO:0060486) |
1.1 | 3.3 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
1.1 | 5.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
1.0 | 3.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.0 | 2.9 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.0 | 1.9 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.0 | 1.0 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
1.0 | 2.9 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.9 | 2.8 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.9 | 3.7 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.9 | 3.7 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.9 | 2.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.9 | 6.8 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.8 | 2.4 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.7 | 2.2 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.7 | 2.9 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.7 | 2.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.7 | 2.1 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.7 | 4.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.7 | 2.6 | GO:0030035 | microspike assembly(GO:0030035) |
0.6 | 1.3 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.6 | 1.9 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.6 | 3.2 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.6 | 6.9 | GO:0071625 | vocalization behavior(GO:0071625) |
0.6 | 2.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.6 | 4.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.6 | 2.4 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.6 | 2.4 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.6 | 1.8 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.6 | 2.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.6 | 2.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.6 | 0.6 | GO:1903273 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
0.6 | 0.6 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.6 | 1.7 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.5 | 2.7 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.5 | 2.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.5 | 5.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.5 | 1.0 | GO:1904395 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.5 | 1.5 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.5 | 1.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.5 | 1.0 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.5 | 1.5 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.5 | 0.5 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.5 | 3.9 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.5 | 2.4 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.5 | 1.5 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.5 | 1.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 1.5 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.5 | 1.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.5 | 1.4 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.5 | 1.0 | GO:0021637 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
0.5 | 1.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.5 | 2.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.5 | 3.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.5 | 0.9 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.5 | 1.8 | GO:0060005 | vestibular reflex(GO:0060005) |
0.5 | 1.4 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.5 | 1.8 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.5 | 1.4 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.4 | 0.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.4 | 0.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.4 | 0.9 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.4 | 2.2 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.4 | 3.9 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.4 | 1.3 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.4 | 0.9 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.4 | 0.4 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.4 | 1.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.4 | 2.5 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.4 | 0.8 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.4 | 2.5 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.4 | 0.8 | GO:1903416 | response to glycoside(GO:1903416) |
0.4 | 0.4 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.4 | 3.8 | GO:0060013 | righting reflex(GO:0060013) |
0.4 | 0.8 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.4 | 2.4 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.4 | 3.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.4 | 0.4 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.4 | 1.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 1.6 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.4 | 3.1 | GO:0007614 | short-term memory(GO:0007614) |
0.4 | 2.3 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.4 | 1.5 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.4 | 2.3 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.4 | 0.4 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.4 | 1.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.4 | 0.4 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.4 | 0.7 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.4 | 0.7 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.4 | 2.6 | GO:0097264 | self proteolysis(GO:0097264) |
0.4 | 1.5 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.4 | 4.8 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.4 | 1.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.4 | 1.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 1.4 | GO:0060174 | limb bud formation(GO:0060174) |
0.4 | 0.4 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.4 | 2.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.4 | 0.7 | GO:0030421 | defecation(GO:0030421) |
0.4 | 2.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.4 | 1.1 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.4 | 2.5 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.4 | 0.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.4 | 1.8 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.3 | 3.1 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.3 | 2.1 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.3 | 3.8 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.3 | 0.7 | GO:0060618 | nipple development(GO:0060618) |
0.3 | 4.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.3 | 0.7 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.3 | 17.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 1.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 0.7 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.3 | 3.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 1.0 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 1.3 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.3 | 1.3 | GO:0086005 | ventricular cardiac muscle cell action potential(GO:0086005) |
0.3 | 1.6 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.3 | 2.6 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.3 | 1.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 1.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.3 | 1.3 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.3 | 1.3 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.3 | 0.6 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.3 | 0.9 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 0.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.3 | 1.6 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.3 | 0.9 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.3 | 1.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.3 | 1.5 | GO:0035989 | tendon development(GO:0035989) |
0.3 | 1.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 0.3 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.3 | 1.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.3 | 2.9 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.3 | 0.9 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.3 | 0.9 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 2.3 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.3 | 0.9 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.3 | 2.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.3 | 0.9 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.3 | 0.9 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.3 | 1.1 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.3 | 0.9 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.3 | 0.9 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.3 | 1.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.3 | 0.3 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.3 | 0.3 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.3 | 1.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 0.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 0.8 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.3 | 1.1 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.3 | 0.5 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.3 | 0.8 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.3 | 0.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 0.5 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 0.5 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.3 | 2.1 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.3 | 0.5 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.3 | 2.6 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.3 | 1.1 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.3 | 0.5 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.3 | 0.8 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.3 | 0.8 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 0.5 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.3 | 1.3 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.3 | 2.5 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.3 | 1.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 1.0 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 0.7 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.2 | 0.7 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 3.4 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 3.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 1.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 0.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 0.7 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.2 | 0.7 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.2 | 4.3 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 1.2 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.2 | 0.5 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.2 | 0.2 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 0.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.9 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.7 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.2 | 0.7 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.2 | 0.9 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.2 | 0.5 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.2 | 0.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 1.1 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.2 | 1.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 0.4 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.2 | 0.2 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.2 | 1.7 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.2 | 0.7 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.7 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.2 | 0.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 0.4 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.2 | 1.7 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 0.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.2 | 4.7 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 0.8 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 0.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.4 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.2 | 0.4 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 0.4 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.2 | 0.6 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.2 | 3.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.2 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
0.2 | 0.4 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.2 | 0.4 | GO:0050904 | diapedesis(GO:0050904) |
0.2 | 0.6 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 0.8 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 1.6 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.2 | 0.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 0.4 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.2 | 0.8 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.2 | 1.0 | GO:0022605 | oogenesis stage(GO:0022605) |
0.2 | 0.2 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 0.6 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.2 | 1.0 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.2 | 1.0 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 3.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 0.8 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.2 | 2.7 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.2 | 2.1 | GO:0060384 | innervation(GO:0060384) |
0.2 | 0.6 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 0.2 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.2 | 0.2 | GO:0061337 | cardiac conduction(GO:0061337) |
0.2 | 0.9 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 0.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 0.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.9 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.2 | 0.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 1.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.2 | 0.2 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.2 | 0.2 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.2 | 0.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 | 0.5 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.9 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.2 | 4.4 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 0.5 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.2 | 0.9 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 2.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 0.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.2 | 0.5 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.2 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 0.3 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 1.0 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.2 | 1.4 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.2 | 0.5 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.2 | 1.4 | GO:0098739 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) import across plasma membrane(GO:0098739) sodium ion import into cell(GO:1990118) |
0.2 | 0.5 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.2 | 0.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 0.5 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 3.3 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.2 | 0.8 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.2 | 0.8 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.2 | 0.7 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 0.2 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.2 | 0.6 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.2 | 1.0 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.2 | 0.5 | GO:0015817 | histidine transport(GO:0015817) |
0.2 | 3.9 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.2 | 0.6 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 0.8 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.2 | 0.3 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.2 | 0.3 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.2 | 0.3 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.2 | 1.7 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 2.1 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.2 | 0.6 | GO:0031000 | response to caffeine(GO:0031000) |
0.2 | 0.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.2 | 0.8 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 0.5 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.2 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
0.2 | 0.3 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.2 | 0.6 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.2 | 0.2 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.2 | 1.5 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 2.3 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.2 | 0.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 0.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 0.2 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.1 | 0.4 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.6 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.9 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 2.7 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.1 | 0.4 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.9 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.1 | 0.9 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.1 | 0.4 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.4 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.1 | 3.3 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 1.0 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.1 | 0.6 | GO:0060004 | reflex(GO:0060004) |
0.1 | 0.3 | GO:0090135 | actin filament branching(GO:0090135) |
0.1 | 0.3 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.7 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 0.1 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.1 | 0.6 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.3 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.4 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.3 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 1.5 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 0.9 | GO:0060482 | lobar bronchus development(GO:0060482) |
0.1 | 1.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.8 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.7 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 1.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.1 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 0.4 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.1 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 0.4 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.4 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.1 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.1 | 9.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 1.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.3 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.3 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.3 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.1 | 0.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.1 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.1 | 0.1 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 0.4 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.9 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.4 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.1 | 0.1 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.7 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.1 | 1.2 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.4 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 0.1 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.1 | 0.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 1.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.2 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.1 | 1.8 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.9 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.5 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.1 | GO:0021586 | pons maturation(GO:0021586) |
0.1 | 0.3 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.1 | 1.4 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.1 | 0.1 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.1 | 0.5 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.1 | 0.1 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.1 | 0.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.1 | 0.5 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 1.2 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.3 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 | 0.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 2.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.4 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.4 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 1.6 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.3 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.5 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.1 | 0.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.2 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.3 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.8 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.2 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.1 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.1 | 0.4 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.4 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.1 | 1.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 1.5 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.2 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.3 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.4 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.1 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.5 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.5 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.1 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.1 | 0.3 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.3 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.1 | 0.7 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.8 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.6 | GO:0032328 | alanine transport(GO:0032328) |
0.1 | 0.6 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.1 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.1 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 1.6 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.5 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 0.1 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.2 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 0.3 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.9 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.1 | 0.4 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.4 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.1 | 0.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.1 | 0.2 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.1 | 0.3 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.1 | 0.1 | GO:0033483 | gas homeostasis(GO:0033483) |
0.1 | 0.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.7 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.7 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 0.3 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 1.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 5.2 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.1 | 0.9 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.1 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.1 | 0.4 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 0.2 | GO:0036492 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
0.1 | 0.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.1 | 0.1 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
0.1 | 0.2 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.3 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.1 | 0.4 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.1 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.1 | 0.2 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.6 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 0.3 | GO:0086003 | cardiac muscle cell contraction(GO:0086003) |
0.1 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.1 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.6 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.1 | 0.2 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.1 | 0.2 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.1 | 0.3 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.5 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.1 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.1 | 0.1 | GO:0060433 | bronchus development(GO:0060433) |
0.1 | 2.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.5 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.1 | 0.2 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 0.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.1 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 0.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.1 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 1.1 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 2.3 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.1 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.2 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.3 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.4 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.1 | 0.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.5 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.1 | 0.4 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.7 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.9 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.1 | 0.2 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.1 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.3 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.6 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 2.2 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.6 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.6 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 1.7 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.1 | 0.6 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.1 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.1 | 0.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.2 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.5 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 0.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.1 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.1 | 0.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.3 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.1 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.1 | 1.5 | GO:0050808 | synapse organization(GO:0050808) |
0.1 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.1 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.1 | 0.2 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.6 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.1 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.1 | 0.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.3 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) |
0.1 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.3 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.6 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.1 | 0.2 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.1 | 0.9 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 2.5 | GO:0006941 | striated muscle contraction(GO:0006941) |
0.1 | 0.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.7 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.4 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.4 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.4 | GO:0030828 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.2 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.1 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.3 | GO:0042220 | response to cocaine(GO:0042220) |
0.1 | 0.8 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.1 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.6 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.3 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.1 | 0.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 3.1 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.3 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.1 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.1 | 0.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.1 | 0.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.2 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 1.5 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.1 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.3 | GO:0043368 | positive T cell selection(GO:0043368) |
0.1 | 0.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.2 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.1 | 0.2 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 0.4 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.2 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.1 | 0.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.1 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.1 | 0.1 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.1 | 0.1 | GO:0003289 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.1 | 0.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.5 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.1 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.1 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.1 | 0.2 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
0.1 | 0.1 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) |
0.1 | 0.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.6 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 1.1 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 0.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.9 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.1 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.0 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.0 | 0.9 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.0 | 0.2 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.1 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.0 | 0.3 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.0 | 0.3 | GO:0051044 | regulation of membrane protein ectodomain proteolysis(GO:0051043) positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.2 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.0 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.8 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.0 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
0.0 | 0.0 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.0 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 1.5 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.0 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.0 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.0 | 0.2 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.1 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.0 | 0.0 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.6 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.0 | GO:0061198 | maintenance of chromatin silencing(GO:0006344) fungiform papilla formation(GO:0061198) |
0.0 | 0.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.2 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.0 | 0.2 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.0 | 0.2 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.0 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.0 | 0.0 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.1 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.1 | GO:0061140 | lung secretory cell differentiation(GO:0061140) |
0.0 | 0.2 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.4 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.0 | 0.0 | GO:0060166 | olfactory pit development(GO:0060166) |
0.0 | 0.4 | GO:1902751 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.2 | GO:0071711 | basement membrane organization(GO:0071711) |
0.0 | 0.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.8 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.1 | GO:0051954 | positive regulation of amine transport(GO:0051954) |
0.0 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.2 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.0 | 0.1 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.0 | GO:0061046 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.0 | 0.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.2 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.0 | 0.1 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.0 | 0.3 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.0 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.0 | 0.4 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.0 | 0.0 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.0 | 0.2 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.1 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.0 | 0.1 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.0 | 0.5 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 0.0 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.0 | 0.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.0 | 0.0 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.0 | 0.3 | GO:0046851 | negative regulation of bone remodeling(GO:0046851) |
0.0 | 0.2 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) |
0.0 | 0.1 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.0 | 0.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.6 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.1 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.0 | 0.1 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.2 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.0 | 0.0 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.0 | 0.1 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.0 | 0.6 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.0 | 0.0 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.0 | 1.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.0 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.0 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 1.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.0 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.0 | 0.0 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.0 | 0.8 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.0 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.0 | 0.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.0 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.0 | 0.6 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.3 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.0 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.2 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.0 | 0.0 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.0 | 0.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.0 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.1 | GO:0006901 | vesicle coating(GO:0006901) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.2 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.0 | 0.1 | GO:0015867 | ATP transport(GO:0015867) |
0.0 | 0.0 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.3 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.0 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.0 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.0 | 0.0 | GO:1902946 | protein localization to early endosome(GO:1902946) |
0.0 | 0.2 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.1 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.3 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.0 | 0.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.0 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.0 | 0.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.1 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.0 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
0.0 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.6 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.0 | GO:0044849 | negative regulation of immature T cell proliferation in thymus(GO:0033088) estrous cycle(GO:0044849) |
0.0 | 0.5 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.0 | 0.1 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.2 | GO:0042596 | fear response(GO:0042596) |
0.0 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.4 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.0 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.0 | 0.2 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.2 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.0 | 0.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.0 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.3 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 0.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.2 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.6 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.0 | 0.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.3 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.3 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.1 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.0 | 0.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.0 | 0.1 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.0 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.0 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.0 | 0.1 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.0 | 0.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.0 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.0 | 0.1 | GO:0003016 | respiratory system process(GO:0003016) |
0.0 | 0.1 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.0 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.0 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.0 | 0.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.0 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.0 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.0 | 0.0 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
0.0 | 0.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.0 | 0.0 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.0 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.3 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.0 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.0 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.1 | GO:0090109 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) |
0.0 | 0.1 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.1 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.0 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.3 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.0 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.0 | 0.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.0 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.0 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.0 | 0.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.0 | 0.0 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.2 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.0 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.0 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.0 | 0.0 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.0 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.0 | 0.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.0 | GO:0002434 | immune complex clearance(GO:0002434) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.0 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.0 | 0.4 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.0 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.0 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.0 | 0.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.9 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.3 | 3.8 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.8 | 6.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.8 | 2.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.7 | 3.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.7 | 2.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.6 | 0.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.6 | 3.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.6 | 3.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.6 | 4.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.6 | 1.8 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.5 | 7.9 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.5 | 2.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 1.7 | GO:0044308 | axonal spine(GO:0044308) |
0.4 | 3.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 1.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.4 | 1.3 | GO:0072534 | perineuronal net(GO:0072534) |
0.4 | 3.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.4 | 3.3 | GO:0005861 | troponin complex(GO:0005861) |
0.4 | 10.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.4 | 3.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 3.3 | GO:0005883 | neurofilament(GO:0005883) |
0.4 | 4.7 | GO:0043034 | costamere(GO:0043034) |
0.3 | 0.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 2.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 1.0 | GO:0043511 | inhibin complex(GO:0043511) |
0.3 | 1.6 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.3 | 6.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 3.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 4.2 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 2.1 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.3 | 1.7 | GO:0031983 | vesicle lumen(GO:0031983) |
0.3 | 0.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 2.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.3 | 1.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.3 | 0.5 | GO:0097433 | dense body(GO:0097433) |
0.3 | 0.5 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.3 | 2.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 2.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 0.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 0.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 0.5 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 0.7 | GO:0097513 | myosin II filament(GO:0097513) |
0.2 | 0.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 1.8 | GO:0043679 | axon terminus(GO:0043679) |
0.2 | 2.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 6.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 5.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 17.1 | GO:0031674 | I band(GO:0031674) |
0.2 | 2.6 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 34.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 0.8 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 1.4 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 2.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 2.6 | GO:0097060 | synaptic membrane(GO:0097060) |
0.2 | 5.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 2.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 9.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 1.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 2.4 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 4.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 0.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 1.2 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 15.8 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.2 | 0.5 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 0.2 | GO:0031523 | Myb complex(GO:0031523) |
0.2 | 2.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 3.1 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 0.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 0.3 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 0.5 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 1.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 2.3 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 3.8 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 1.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.5 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 1.5 | GO:0031672 | A band(GO:0031672) |
0.1 | 7.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 1.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.4 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 8.2 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 1.5 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 0.6 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.8 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 2.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.5 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 2.9 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 1.0 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 0.2 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 4.5 | GO:0005901 | caveola(GO:0005901) |
0.1 | 1.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.3 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 3.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.8 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.7 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 1.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 0.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 4.4 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.9 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 1.0 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.8 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 8.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.6 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 1.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.5 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 1.1 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.6 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 1.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 11.5 | GO:0030425 | dendrite(GO:0030425) |
0.1 | 0.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.7 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.3 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.4 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.0 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 0.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.3 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.4 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.0 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.7 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.2 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 5.6 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 0.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.0 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 6.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.1 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 0.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.5 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.0 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 1.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.0 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.0 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.0 | 0.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) collagen type IX trimer(GO:0005594) |
0.0 | 0.4 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.9 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.3 | 3.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.1 | 3.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.9 | 3.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.8 | 3.4 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.8 | 2.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.7 | 2.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.7 | 2.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.7 | 5.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.7 | 1.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.6 | 1.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.6 | 2.4 | GO:0031433 | telethonin binding(GO:0031433) |
0.6 | 3.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.6 | 2.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.6 | 1.8 | GO:0030172 | troponin C binding(GO:0030172) |
0.6 | 1.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.6 | 2.8 | GO:0071253 | connexin binding(GO:0071253) |
0.6 | 1.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.6 | 1.7 | GO:0070538 | oleic acid binding(GO:0070538) |
0.5 | 2.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.5 | 4.7 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.5 | 1.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.5 | 2.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.4 | 1.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 2.6 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.4 | 3.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.4 | 1.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 1.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.4 | 0.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.4 | 2.4 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.4 | 1.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.4 | 2.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.4 | 3.1 | GO:0031432 | titin binding(GO:0031432) |
0.4 | 3.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.4 | 1.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 8.4 | GO:0004118 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.4 | 1.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 3.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.4 | 1.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.4 | 1.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.4 | 0.7 | GO:0031013 | troponin I binding(GO:0031013) |
0.4 | 1.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.4 | 1.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.4 | 1.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.4 | 1.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 2.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 1.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 1.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 4.3 | GO:0031402 | sodium ion binding(GO:0031402) |
0.3 | 2.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 1.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 0.6 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.3 | 1.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 1.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 1.9 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 1.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 1.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 3.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.3 | 1.2 | GO:0009374 | biotin binding(GO:0009374) |
0.3 | 0.9 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 1.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 0.9 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.3 | 2.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.3 | 0.9 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.3 | 0.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 1.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 1.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.3 | 2.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 5.0 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 0.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.3 | 1.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 1.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.3 | 6.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 3.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.3 | 1.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 0.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 1.6 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.3 | 0.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 0.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 0.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 1.0 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.3 | 1.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 1.0 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 1.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 1.8 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.3 | 1.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 2.5 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 2.5 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 3.0 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 2.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 0.5 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 3.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.2 | 0.5 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 4.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 1.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 1.4 | GO:0033265 | choline binding(GO:0033265) |
0.2 | 0.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 0.5 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 0.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.2 | 2.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 0.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.2 | 0.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 1.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 0.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 0.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 0.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 1.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 0.7 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 1.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 5.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 0.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 0.6 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 4.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 1.0 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 1.2 | GO:0016631 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.2 | 0.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 0.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 0.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 0.6 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 1.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 0.4 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 4.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 0.7 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.4 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 2.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 1.4 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 4.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 0.7 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 4.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 0.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 1.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 5.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 0.8 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 1.0 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 0.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 1.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 0.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 1.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.2 | 1.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 1.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.5 | GO:0036403 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.2 | 0.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 2.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 0.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 0.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.2 | 3.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 0.9 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.2 | 1.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 0.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 1.3 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.1 | 0.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 0.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 1.8 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.3 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 3.4 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 0.7 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.7 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 1.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 1.9 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 1.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 1.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 1.0 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.2 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 1.2 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.1 | 0.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 1.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.4 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 2.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 1.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.1 | 1.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 1.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 1.0 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 1.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 1.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.6 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.7 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 1.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.2 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.1 | 0.7 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 4.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.4 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 0.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 1.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.1 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 0.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 6.8 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 0.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.5 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 1.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.4 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 1.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 1.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 1.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 0.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.7 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 1.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.2 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.1 | 0.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 1.5 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 2.0 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 6.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.4 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.1 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.1 | 0.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.6 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.3 | GO:0016885 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.1 | 0.4 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 1.9 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 1.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 1.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 1.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 1.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.3 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 1.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 1.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 1.3 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 3.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 3.0 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.1 | 3.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 1.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 1.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 1.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 1.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.2 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 1.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.2 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.3 | GO:0030594 | neurotransmitter receptor activity(GO:0030594) |
0.1 | 1.0 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 8.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 1.5 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.7 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 2.1 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.7 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 1.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 1.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.2 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.0 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 0.6 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 9.5 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.1 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.7 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.2 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0018636 | phenanthrene 9,10-monooxygenase activity(GO:0018636) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.4 | GO:0043748 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 2.2 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.2 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.2 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.0 | 0.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.2 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.0 | 0.7 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.5 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 1.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.2 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.0 | 0.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.1 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 1.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 1.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.0 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 0.0 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.4 | GO:0043914 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) NADPH:sulfur oxidoreductase activity(GO:0043914) epoxyqueuosine reductase activity(GO:0052693) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.0 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.0 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.2 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.0 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.0 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.0 | 0.0 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.0 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.0 | 0.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.0 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.0 | 0.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 2.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 2.6 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 0.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 3.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 3.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 2.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 4.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 4.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 2.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 0.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 1.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 3.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.8 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 4.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 1.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 3.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 2.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 2.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 3.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 1.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 3.0 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 4.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 13.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 3.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 1.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 2.0 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 2.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 1.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 1.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 1.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 6.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 1.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 10.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.5 | 6.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 5.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.4 | 1.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.4 | 4.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 7.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 2.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.3 | 8.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 3.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 2.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 6.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 0.5 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.3 | 2.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 2.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 4.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 5.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 3.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 4.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 2.8 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 1.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 3.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 2.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 4.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 0.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 0.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 5.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 2.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 3.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 1.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 1.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 7.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 1.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 0.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 1.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 1.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.8 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 1.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 1.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 2.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 1.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 4.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 0.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 9.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.8 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 1.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 3.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.6 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 2.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.8 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.4 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 0.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.2 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 0.6 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.1 | 0.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 0.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 3.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 2.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 5.8 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 0.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.0 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.5 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 1.1 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 2.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.1 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.4 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |